KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 133 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,910,700 | +23.4% | 110,000 | 0.0% | 1.08% | +26.2% |
| Q2 2023 | $1,548,800 | +74.5% | 110,000 | +33.3% | 0.86% | +40.1% |
| Q1 2023 | $887,700 | +31.7% | 82,500 | +83.3% | 0.61% | -8.0% |
| Q4 2022 | $674,100 | +22.1% | 45,000 | +4.7% | 0.67% | +17.7% |
| Q3 2022 | $552,000 | +21.9% | 43,000 | +32.3% | 0.57% | +360.2% |
| Q2 2021 | $453,000 | +28.7% | 32,500 | +71.1% | 0.12% | +3.4% |
| Q1 2021 | $352,000 | +28.5% | 19,000 | +22.6% | 0.12% | +4.4% |
| Q4 2020 | $274,000 | +349.2% | 15,500 | +287.5% | 0.11% | +280.0% |
| Q3 2020 | $61,000 | – | 4,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |